Benefit from adrenocorticotrophin in myasthenia gravis. Issue 4 (April 1974)

• Record Type: Journal Article
• Authors: Liversedge, L. A.; Yuill, G. M.; Wilkinson, I. M. S.; Hughes, J. A.
• Is Part Of: Journal of neurology, neurosurgery and psychiatry. Volume 37:Issue 4(1974)
• Page Start: 412
• Page End: 415
• Publication Date: 1974-04
• Subjects: Neurology -- Periodicals; Nervous system -- Surgery -- Periodicals; Psychiatry -- Periodicals; 616.8
• DOI: 10.1136/jnnp.37.4.412
• Languages: English
• ISSNs: 0022-3050

Abstract

Abstract : Twenty-one of 29 patients suffering from myasthenia gravis derived benefit from a short intensive course of adrenocorticotrophin (ACTH). The mean duration of benefit was approximately six months. The best results were obtained in patients with a short history of myasthenia. Transient deterioration during the course of injections was encountered in some cases but necessitated assisted respiration only in patients with severe generalized weakness before treatment.